Effects of nicotinic acetylcholine receptor-activating alkaloids on anxiety-like behavior in zebrafish
Authors:
- Ainhoa AlzualdeAAAinhoa Alzualde
- Oihane JakaOJOihane Jaka
- Diogo A. R. S. LatinoDLDiogo A. R. S. Latino
- Omar AlijevicOAOmar Alijevic
- Iñaki IturriaIIIñaki Iturria
- Pavel PospisilPPPavel Pospisil
- Stefan FrentzelSFStefan Frentzel
- Manuel C. PeitschMPManuel C. Peitsch
- Julia HoengJHJulia Hoeng
- Kyoko KoshibuKKKyoko Koshibu
Open Access
- 15 July 2021
- journal article
- research article
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 75 (4) , 926-941
Abstract
Alkaloids are a structurally complex group of natural products that have a diverse range of biological activities and significant therapeutic applications. In this study, we examined the acute, anxiolytic-like effects of nicotinic acetylcholine receptor (nAChR)-activating alkaloids with reported neuropharmacological effects but whose effects on anxiety are less well understood. Because α4β2 nAChRs can regulate anxiety, we first demonstrated the functional activities of alkaloids on these receptors in vitro. Their effects on anxiety-like behavior in zebrafish were then examined using the zebrafish novel tank test (NTT). The NTT is a relatively high-throughput behavioral paradigm that takes advantage of the natural tendency of fish to dive down when stressed or anxious. We report for the first time that cotinine, anatabine, and methylanatabine may suppress this anxiety-driven zebrafish behavior after a single 20-min treatment. Effective concentrations of these alkaloids were well above the concentrations naturally found in plants and the concentrations needed to induce anxiolytic-like effect by nicotine. These alkaloids showed good receptor interactions at the α4β2 nAChR agonist site as demonstrated by in vitro binding and in silico docking model, although somewhat weaker than that for nicotine. Minimal or no significant effect of other compounds may have been due to low bioavailability of these compounds in the brain, which is supported by the in silico prediction of blood–brain barrier permeability. Taken together, our findings indicate that nicotine, although not risk-free, is the most potent anxiolytic-like alkaloid tested in this study, and other natural alkaloids may regulate anxiety as well.Keywords
Funding Information
- Philip Morris International
This publication has 71 references indexed in Scilit:
- Systematic Screening of Behavioral Responses in Two Zebrafish StrainsZebrafish, 2013
- The role of zebrafish (Danio rerio) in dissecting the genetics and neural circuits of executive functionFrontiers in Neural Circuits, 2013
- admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET PropertiesJournal of Chemical Information and Modeling, 2012
- Variability in docking success rates due to dataset preparationJournal of Computer-Aided Molecular Design, 2012
- Modeling anxiety using adult zebrafish: A conceptual reviewNeuropharmacology, 2012
- Zebrafish for the Study of the Biological Effects of NicotineNicotine & Tobacco Research, 2011
- Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafishBehavioural Brain Research, 2009
- Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxietyPharmacology Biochemistry and Behavior, 2009
- The role of α7 and α4β2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafishPhysiology & Behavior, 2008
- The Protein Data BankNucleic Acids Research, 2000